The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects
Nutrients · 21.11.2023 · 15 (23) · 4856
DOI: 10.3390/nu15234856 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 21.11.2023. Verfasst von Hans Van der Eecken und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital Brussels, 1090 Brussels, Belgium. Hauptthemen laut MEDLINE: Isoflavones, Prostatic Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A possible link between diet and cancer has long been considered, with growing interest in phytochemicals. Soy isoflavones have been associated with a reduced risk of prostate cancer in Asian populations. Of the soy isoflavones, genistein and daidzein, in particular, have been studied, but recently, equol as a derivative has gained interest because it is more biologically potent. Different mechanisms of action have already been studied for the different isoflavones in multiple conditions, such as breast, gastrointestinal, and urogenital cancers. Many of these mechanisms of action could also be demonstrated in the prostate, both in vitro and in vivo. This review focuses on the known mechanisms of action at the cellular level and compares them between genistein, daidzein, and equol. These include androgen- and estrogen-mediated pathways, regulation of the cell cycle and cell proliferation, apoptosis, angiogenesis, and metastasis. In addition, antioxidant and anti-inflammatory effects and epigenetics are addressed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, University Hospital Brussels, 1090 Brussels, Belgium.
- Department of Urology, University Hospitals Leuven, 3000 Leuven, Belgium.
- Department of Radiation Oncology, University Hospitals Leuven, 3000 Leuven, Belgium.
ORCID-Profile: Hans Van der Eecken, Steven Joniau, Charlien Berghen
Zitieren
APA
Van der Eecken, H., Joniau, S., Berghen, C., Rans, K., & De Meerleer, G. (2023). The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects. Nutrients, 15(23), 4856. https://doi.org/10.3390/nu15234856
Vancouver
Van der Eecken H, Joniau S, Berghen C, Rans K, De Meerleer G. The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects. Nutrients. 2023;15(23):4856. doi:10.3390/nu15234856
BibTeX
@article{VanderEecken2023,
author = {Van der Eecken, Hans and Joniau, Steven and Berghen, Charlien and Rans, Kato and De Meerleer, Gert},
title = {The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {23},
pages = {4856},
doi = {10.3390/nu15234856}
}
EUVIMED